Magna Capital Partners
VC Fund
Chicago, United States
Magna Capital Partners is a venture capital firm that invests in startups established in the State of Israel. The company is primarily focused on industrial products, healthcare products, and distribution sectors.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Magna Capital Partners invests in
Stages Magna Capital Partners invests in
Countries Magna Capital Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $350k–$3.5M
- Series A
- $3.3M–$27M
Investment Focus
Industry
- Software 4 (22%)
- Health Care 3 (17%)
- Biotechnology 3 (17%)
- Medical 2 (11%)
- Big Data 2 (11%)
Stage
- Seed 5 (28%)
- Series A 5 (28%)
- Funding Round 3 (17%)
- Series B 2 (11%)
- Pre-Seed 1 (6%)
Country
- Israel 6 (33%)
- United States 2 (11%)
- France 1 (6%)
- Mexico 1 (6%)
- Argentina 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Carlos Gari
Co-Founder & Associate Partner
|
Co-Founder & Associate Partner | Total investments: 0 | Find email | |
Shimon Elkabetz
Investment Partner
|
Investment Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Aviva is building an AI-powered digital bank for Latin America’s underserved communities. While determined to fuel Latin America’s ongoing emergence of a new middle class with a fully-fledged portfolio of inclusive financial services, Aviva’s initial go-to-market concentrates on unsecured credit products for individuals and nano-businesses inMexico.As most of the underbanked 40+ million Mexicans live in small and medium-sized towns, Aviva builds a bridge to those living in remote communities with its physical onboarding kiosks. These nano-branches provide a documentless 3-minute video onboarding for everyone in need of liquidity. Novel AI-based technology, including natural language processing, allows Aviva to match customers’ spoken word to the fields of a comprehensive real-time credit application. Transforming speech to text and inferring emotions and personality from the visual layer of the application video gives Aviva an edge in scoring thin-file customers. Leveraging these novel risk models, Aviva aims to provide the lowest interest rates available to today’s underserved. | $2.2M / Pre-Seed / Dec 16, 2022 | ||
| Constru offers a breakthrough computer vision technology to superpower the engineering and project management teams onsite, monitoring every job, on every wall, throughout the construction process. The system collects and analyses photographic data and generates prescriptive insights to support business decisions and help the teams reliably delivertop-quality projects on time and on budget. | $8M / Series A / Sep 28, 2022 | ||
| Konnecto offers the world’s first prescriptive marketing platform that provides consumer brands with daily recommendations on how to increase their online sales by reverse engineering their competitors’ journeys and identifying path-to-purchase vulnerabilities. Konnecto works with companies across a variety of industries, including Coca-Cola,MyHeritage, AON, Haven Life, and many others | $21M / Series A / Jun 28, 2022 | ||
| Kitchenita is a Buenos Aires based startup that creates data-driven food concepts for delivery. Through data analysis and proprietary technology, we launch online native food brands that we position in the top 10 of its vertical in less than a month. | $3M / Seed / Feb 01, 2022 | ||
| Addionics is creating next-generation batteries through intelligent 3D battery architecture and engineering. It provides specialized improved rechargeable batteries by redesigning their architecture.With the largest markets in mind, the company invents new energy storage with higher energy density, lower charging time, and improved heat safety.Addionics is developing a new technology that transforms how energy is stored and delivered, positively impacting the environment. Today, the company is accelerating the development and scale-up of its proprietary technology to create the next generation of batteries to power the future. It provides specialized improved rechargeable batteries by redesigning their architecture. | $27M / Series A / Jan 25, 2022 | ||
| Konnecto offers the world’s first prescriptive marketing platform that provides consumer brands with daily recommendations on how to increase their online sales by reverse engineering their competitors’ journeys and identifying path-to-purchase vulnerabilities. Konnecto works with companies across a variety of industries, including Coca-Cola,MyHeritage, AON, Haven Life, and many others | May 01, 2021 | ||
| PEP-Therapy is a biotechnology company developing first-in-class peptides as targeted therapies for severe diseases, with an initial focus on cancer. PEP-Therapy develops Cell Penetrating and Interfering Peptides (CP&IP) for the intracellular delivery of targeted therapies. These active compounds penetrate cells and block relevantintracellular protein-protein interactions, thus inhibiting key pathological mechanisms. | $3.3M / Series A / Apr 22, 2021 | ||
| TechsoMed is an Israeli based medical device company, developing ultrasound based real-time monitoring systems for thermal ablation procedures. The applications of thermal ablation are numerous: tumor destruction, heart arrhythmia, blood pressure treatments and more. The procedure has market size in the billions, but lacks real-time monitoringcapabilities, causing high failure rates.Their technology offers added value to patients, physicians and insurance companies by solving the high failure rate of these minimally invasive and cost effective procedures. | $7M / Series B / Mar 03, 2021 | ||
| Konnecto offers the world’s first prescriptive marketing platform that provides consumer brands with daily recommendations on how to increase their online sales by reverse engineering their competitors’ journeys and identifying path-to-purchase vulnerabilities. Konnecto works with companies across a variety of industries, including Coca-Cola,MyHeritage, AON, Haven Life, and many others | $3.5M / Seed / Nov 23, 2020 | ||
| Geneyx is a computer software company that offers an integrated cloud-based genetic data platform. Geneyx platform offers genetic testing labs and hospital-based facilities, advanced data management, a seamless pipeline from fastq files to VCF. Best of breed analysis software powered by The Weizmann Institute of Science's GeneCards knowledgesuite and secured GDPR/HIPAA/CCPA compliant storage systems. Geneyx enables Pharma, universities, and institute based research groups to spearhead the development of innovative drugs, novel therapeutic and diagnostic tools. | $500K / Seed / Aug 28, 2020 | ||
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Magna Capital Partners invest in?
Magna Capital Partners invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 18 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Magna Capital Partners's check size?
Magna Capital Partners typically joins rounds of $350k–$3.5M at Seed and $3.3M–$27M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Magna Capital Partners participates in.
How do I contact Magna Capital Partners?
Public channels for Magna Capital Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Magna Capital Partners?
The team at Magna Capital Partners includes Carlos Gari (Co-Founder & Associate Partner) and Shimon Elkabetz (Investment Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
